Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HK2 | P52789 | 6/20 | 0.41 |
| ▸ | HK1 | P19367 | 5/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CD69 | Q07108 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metrizamide SCHEMBL16984723 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL24383 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL24382 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL8678604 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL11048850 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL433082 | 0.87 | LMNA (0.76) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL17909957 | 0.87 | LMNA (0.75) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Iohexol SCHEMBL28086756 | 0.85 | LMNA (0.73) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| SCHEMBL18923658 | 0.84 | LMNA (0.72) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Ioxaglic Acid SCHEMBL28143605 | 0.84 | LMNA (0.70) | LMNAKDM4ECYP2D6CYP2C19HK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240200037-A1 | METHOD FOR PRODUCING VIRUS PARTICLES | THE UNIVERSITY OF TOKYO (JP) | 2024-06-20 | — | — | US | claimed |
| EP-4324907-A1 | METHOD FOR PRODUCING VIRUS PARTICLES | The University of Tokyo (JP) | 2024-02-21 | — | — | EP | claimed |
| CN-117178054-A | Method for producing virus particles | 国立大学法人东京大学 | 2023-12-05 | — | — | CN | claimed |
| WO-2022220273-A1 | METHOD FOR PRODUCING VIRUS PARTICLES | 国立大学法人東京大学 | 2022-10-20 | — | — | WO | claimed |
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| WO-2026101973-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2026090138-A1 | ETHER-CONTAINING RADIOPAQUE POLYAMINO CROSSLINKERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026090048-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260108250-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108355-A1 | DEMINERALIZED BONE FIBER COMPOSITION FOR USE IN MINIMALLY INVASIVE SURGERY | ARTERIOCYTE MEDICAL SYSTEMS, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20070041906-A1 | Bone substitute composition | BONE SUPPORT AB (SE) | 2007-02-22 | — | — | US | disclosed |
| CN-1829543-A | A new bone substitute composition | BONE SUPPORT AB (SE) | 2006-09-06 | — | — | CN | disclosed |
| EP-1601387-A1 | A NEW BONE SUBSTITUTE COMPOSITION | Bone Support AB (SE) | 2005-12-07 | — | — | EP | disclosed |
| US-20050119746-A1 | Bone mineral substitute | BONE SUPPORT AB (SE) | 2005-06-02 | — | — | US | disclosed |
| EP-1465678-A1 | A NEW BONE MINERAL SUBSTITUTE | Bone Support AB (SE) | 2004-10-13 | — | — | EP | disclosed |
| WO-2004078223-A1 | A NEW BONE SUBSTITUTE COMPOSITION | BONE SUPPORT AB (SE) | 2004-09-16 | — | — | WO | disclosed |
| WO-2003053488-A1 | A NEW BONE MINERAL SUBSTITUTE | BONE SUPPORT AB (SE) | 2003-07-03 | — | — | WO | disclosed |
| US-5695742-A | MIXTURE OF NONIONIC ORGANIC COMPOUND COMPRISING TRIIODINATED AROMATIC NUCLEUS HAVING AMIDE SUBSTITUENTS AND COMPOUND COMPRISING TWO SUCH TRIIODINATED AROMATIC NUCLEI COVALENTLY BONDED TOGETHER | DIBRA S.P.A. (IT) | 1997-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | LMNA 2822/4885KDM4E 1347/4885CYP2D6 3233/4885 |
| US-20070041906-A1 | Bone substitute composition | SOST, BMP2, BMP6 | LMNA 4402/4885KDM4E 4621/4885CYP2D6 3991/4885 |
| US-20260108250-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | NPPA, CD47, PLAT | LMNA 198/4885KDM4E 2425/4885CYP2D6 2498/4885 |
| US-20260108355-A1 | DEMINERALIZED BONE FIBER COMPOSITION FOR USE IN MINIMALLY INVASIVE SURGERY | BMP2, COL2A1, COL1A1 | LMNA 1963/4885KDM4E 3878/4885CYP2D6 1402/4885 |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | MMP1, ILK, MMP13 | LMNA 2390/4885KDM4E 992/4885CYP2D6 4224/4885 |
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | CD44, PAM, PLOD3 | LMNA 3220/4885KDM4E 2483/4885CYP2D6 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.